Joint Commission issues alert on safe use of oral blood thinners

The Joint Commission has issued a sentinel event alert to guide healthcare organization in managing the risks associated with direct oral anticoagulants, more commonly known as blood thinners or medications that stop blood from clotting.

Advertisement

Direct oral anticoagulants are used to treat certain blood vessel, heart and lung conditions, such as atrial fibrillation and venous thromboembolism, according to the American Heart Association. However, the bleeding risk among people using these medications is high.
https://www.heart.org/-/media/data-import/downloadables/abh-what-are-doacs-ucm_494807.pdf

The alert provides guidance to healthcare providers and leaders on the safe use and management of direct oral anticoagulants, including the importance of knowing the risks, benefits, side effects and potential antidotes or reversal agents for different anticoagulants and communicating this information to patients.

The alert also includes safety actions, such as creating name awareness for different direct oral anticoagulants among pharmacists, emergency department clinicians and other providers.

More articles on healthcare quality:
Teens and e-cig addiction: What physicians are saying
Missouri tightens rules for reporting Legionnaires’ disease
US physicians treat first sickle cell patient with CRISPR

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.